• Explore /
  • Poster
  • / A phase I study of novel multi-HLA-binding peptides and a new combination of immune adjuvants against solid tumors.

A phase I study of novel multi-HLA-binding peptides and a new combination of immune adjuvants against solid tumors.

Abstract Poster

Authors

null

Hiroto Matsui

Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University, Ube, Japan

Hiroto Matsui , Shoichi Hazama , Koji Tamada , Keiko Udaka , Yasunari Koki , Toshinari Uematsu , Hideki Arima , Hiroyuki Furukawa , Tomoya Miyakawa , Shun Doi , Masahiro Kitahara , Shinsuke Kanekiyo , Yukio Tokumitsu , Yoshihiro Tokuhisa , Kazuhiko Sakamoto , Nobuaki Suzuki , Shigeru Takeda , Shigeru Yamamoto , Shigefumi Yoshino , Hiroaki Nagano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research,Immunotherapy

Sub Track

Vaccines

Clinical Trial Registration Number

UMIN000020440

Citation

J Clin Oncol 35, 2017 (suppl; abstr 3086)

DOI

10.1200/JCO.2017.35.15_suppl.3086

Abstract #

3086

Poster Bd #

181

Abstract Disclosures

Similar Posters

Poster

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

First-in-human study of the cancer peptide vaccine, TAS0313, in patients with advanced solid tumors: Phase I dose-finding part results.

First-in-human study of the cancer peptide vaccine, TAS0313, in patients with advanced solid tumors: Phase I dose-finding part results.

First Author: Noboru Yamamoto

First Author: Sadahisa Ogasawara

First Author: Yang Zhang

First Author: Eric Baudin